Peyronie's disease. Induration penis plastica
Conditions
Interventions
Intervention 1: Control group: In this group, patients will receive intra-plaque injection of verapamil 5 mg (2 cc) (in the form of two one-cc insulin syringes) once a week for 12 weeks. Intervention
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 65 years Chordee degree of less than 45 degrees Ultrasound results confirming the presence of plaque Not being in the active phase of the disease (at least one year) Satisfaction to participate in the study
Exclusion criteria
Exclusion criteria: Having cardiovascular/brain problems History of neurological disorders Arterial and venous insufficiency (confirmed by color Doppler ultrasound) Having uncontrolled blood pressure or diabetes Continuous consumption of nitrate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size of palpable plaques. Timepoint: Before and after the intervention. Method of measurement: Physical examination.;Number of palpable plaques. Timepoint: Before and after the intervention. Method of measurement: Physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Kazemi
Esfahan University of Medical Sciences
Outcome results
None listed